ロード中...
Position of Scientific Oncological Societies Towards Biosimilar Antibodies
First biosimilars of monoclonal antibodies have recently been approved in oncology. Biosimilars enable economic competition, alleviate the financial burden for insurances, and may facilitate access to these drugs in low-income countries. Biosimilars are not completely identical to the original drug....
保存先:
| 出版年: | Breast Care (Basel) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
S. Karger GmbH
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6465735/ https://ncbi.nlm.nih.gov/pubmed/31019436 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000495145 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|